Fibroblast growth factor receptor 4 (FGFR4) mediates signaling to the prolactin but not the FGFR4 promoter

American Journal of Physiology - Endocrinology and Metabolism

Volumn 283, Issue 3 46-3, 2002, Pages

  Yu, Shunjiang ^a   Zheng, Lei ^a,b   Asa, Sylvia L ^b,c   Ezzat, Shereen ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Ets1; Fibroblast growth factor receptor 4; Fibroblast growth factor 19; Ikaros; Pituitary

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 4; PROLACTIN; TRANSCRIPTION FACTOR;

ARTICLE; CELL PROLIFERATION; COMPLEX FORMATION; DNA SEQUENCE; ENZYME ACTIVITY; HEMATOPOIETIC CELL; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; LIGAND BINDING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR BINDING; RECEPTOR UPREGULATION;

EID: 0036710282     PISSN: 01931849     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpendo.00166.2002     Document Type: Article

References (24)

1. Abbass SAA, Asa SL, and Ezzat S. Altered expression of fibroblast growth factor receptors in human pituitary adenomas. J Clin Endocrinol Metab 82: 1160-1166, 1997.
2. Ali J, Mansukhani A, and Basilico C. Fibroblast growth factor receptors 1 and 2 are differentially regulated in murine embryonal carcinoma cells and in response to fibroblast growth factor-4. J Cell Physiol 165: 438-448, 1995.
3. Asa SL, Ramyar L, Murphy PR, Li AW, and Ezzat S. The endogenous fibroblast growth factor-2 antisense gene product regulates pituitary cell growth and hormone production. Mol Endocrinol 15: 589-599, 2001.
4. Becker D, Meier CD, and Herlyn M. Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor. EMBO J 8: 3685-3691, 1989.
5. Crumley G, Bellot F, Kaplow JM, Schlessinger J, Jaye M, and Dionne CA. High-affinity binding and activation of a truncated FGF receptor by both aFGF and bFGF. Oncogene 6: 2255-2262, 1991.
6. Ezzat S. The role of hormones, growth factors and their receptors in pituitary tumorigenesis. Brain Pathol 11: 356-370, 2001.
7. Ezzat S, Horvath E, Kovacs K, Smyth HS, Singer W, and Asa SL. Basic fibroblast growth factor expression by two prolactin and thyrotropin-producing pituitary adenomas. Endocr Pathol 6: 125-134, 1995.
8. Ezzat S, Smyth HS, Ramyar L, and Asa SL. Heterogeneous in vivo and in vitro expression of basic fibroblast growth factor by human pituitary adenomas. J Clin Endocrinol Metab 80: 878-884, 1995.
9. Ezzat S, Zheng L, Yu S, and Asa SL. A soluble dominant negative fibroblast growth factor receptor 4 isoform in human mcf-7 breast cancer cells. Biochem Biophys Res Commun 287: 60-65, 2001.
10. Ezzat S, Zheng L, Zhu XF, Wu GE, and Asa SL. Targeted expression of a human pituitary tumor-derived isoform of FGF receptor-4 recapitulates pituitary tumorigenesis. J Clin Invest 109: 69-78, 2002.
11. Givol D and Yayon A. Complexity of FGF receptors: Genetic basis for structural diversity and functional specificity. FASEB J 6: 3362-3369, 1992.
12. Gonsky R, Herman V, Melmed S, and Fagin J. Transforming DNA sequences present in human prolactin-secreting pituitary tumors. Mol Endocrinol 5: 1687-1695, 1991.
13. Hart KC, Robertson SC, Kanemitsu MY, Meyer AN, Tynan JA, and Donoghue JA. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4. Oncogene 29: 3309-3320, 2000.
14. Ladher RK, Anakwe KU, Gurney AL, Schoenwolf GC, and Francis-West PH. Identification of synergistic signals initiating inner ear development. Science 290: 1965-1967, 2000.
15. LeRiche V, Asa SL, and Ezzat S. Epidermal growth factor and its receptor (EGF-R) in human pituitary adenomas: EGF-R correlates with tumor aggressiveness. J Clin Endocrinol Metab 81: 656-662, 1996.
16. Mason IJ. The ins and outs of fibroblast growth factors. Cell 78: 547-552, 1994.
17. Mohammadi M, Honegger AM, Rotin D, Fischer R, Bellot F, Li W, Dionne CA, Jaye M, Rubinstein M, and Schlessinger J. A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-1. Mol Cell Biol 11: 5068-5078, 1991.
18. Ornitz DM, Zu J, Colvin JS, McEwen DG, MacArthur CA, Coulier F, Gao G, and Goldfarb M. Receptor specificity of the fibroblast growth factor family. J Biol Chem 271: 15292-15297, 1996.
19. Ron D, Reich R, Chedid M, Lengel C, Cohen OE, Chan AM, Neufeld G, Miki T, and Tronick SR. Fibroblast growth factor receptor 4 is a high affinity receptor for both acidic and basic fibroblast growth factor but not for keratinocyte growth factor. J Biol Chem 268: 5388-5394, 1993.
20. Schweppe RE, Frazer-Abel AA, Gutierrez-Hartmann A, and Bradford AP. Functional components of fibroblast growth factor (FGF) signal transduction in pituitary cells. Identification of FGF response elements in the prolactin gene. J Biol Chem 272: 30852-30859, 1997.
21. Vainikka S, Joukov V, Wennstrom S, Bergman M, Pelicci PG, and Alitalo K. Signal transduction by fibroblast growth factor receptor-4 (FGFR-4). Comparison with FGFR-1. J Biol Chem 269: 18320-18326, 1994.
22. Vainikka S, Partanen J, Bellosta P, Coulier F, Basilico C, Jay M, and Alitalo K. Fibroblast growth factor receptor-4 shows novel features in genomic structure, ligand binding and signal transduction. EMBO J 11: 4273-4280, 1992.
23. Xie MH, Holcomb I, Deuel B, Dowd P, Huang A, Vagts A, Foster J, Liang J, Brush J, Gu Q, Hillan K, Goddard A, and Gurney AL. FGF-19, a novel fibroblast growth factor with unique specificity for FGFR4. Cytokine 11: 729-735, 1999.
24. Yu S, Asa SL, and Ezzat S. Fibroblast growth factor receptor 4 is a target for the zinc-finger transcription factor Ikaros in the pituitary. Mol Endocrinol 16: 1069-1078, 2002.